Elicio Therapeutics: FDA Cleared IND application for ELI-002, a Therapeutic Vaccine Targeting Mutated KRAS Cancers – CBI
Homepage /  Press Release /  Elicio Therapeutics: FDA Cleared IND application for ELI-002, a Therapeutic Vaccine Targeting Mutated KRAS Cancers

Press Release

Elicio Therapeutics: FDA Cleared IND application for ELI-002, a Therapeutic Vaccine Targeting Mutated KRAS Cancers